Orthoclone OKT3

Active Ingredient(s): Muromonab-CD3
FDA Approved: * September 14, 1992
Pharm Company: * ORTHO BIOTECH
Category: Immunosuppressive

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Orthoclone OKT3 Overview

Muromonab-CD3 (trade name Orthoclone OKT3, marketed by Janssen-Cilag) is an immunosuppressant drug given to reduce acute rejection in patients with organ transplants.[1][2] It is a monoclonal antibody targeted at the CD3 receptor,[3] a membrane protein on the surface of T cells. It was the first monoclonal antibody to be approved for clinical use in humans.[2] Contents 1 History 2 Indications 3 Pharmacodynamics and chemistry ...

Read more Orthoclone OKT3 Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Muromonab-CD3

Recent Orthoclone OKT3 Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Muromonab-CD3
  • Injection: 5mg/5ml
  • Vial: 1mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Muromonab-CD3 or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 13 November 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA